FENC
NASDAQ
US
Fennec Pharmaceuticals Inc. - Common Stock
$6.42
▲ +$0.01
(+0.16%)
Vol 267K
6
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$262.9M
ROE
431.9%
Margin
-13.0%
D/E
996.68
Beta
0.76
52W
$5–$10
Wall Street Consensus
13 analysts · Apr 20264
Strong Buy
8
Buy
1
Hold
0
Sell
0
Strong Sell
92.3%
Buy Rating
Price Chart
Similar Stocks
ELDN
Eledon Pharmaceuticals Inc
$113.4M
CAMP
CAMP4 Therapeutics Corp
$318.0M
NERV
Minerva Neurosciences Inc
$28.1M
ARCT
Arcturus Therapeutics Holdings Inc
$174.2M
KRRO
Korro Bio Inc
$75.4M
NVCT
Nuvectis Pharma Inc
$193.4M
ANIK
Anika Therapeutics Inc
$138.6M
SABS
SAB Biotherapeutics Inc
P/E 9.5
$178.0M
ELTX
Elicio Therapeutics Inc
$139.2M
Earnings
Beat rate: 40.0%
Next Report
May 11, 2026
EPS Estimate: $0.02
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $0.02 | — | — |
| Dec 2025 | $0.04 | $-0.10 | $-0.14 |
| Sep 2025 | $-0.02 | $-0.02 | +$0.00 |
| Jun 2025 | $-0.04 | $-0.11 | $-0.07 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | 431.9% | 431.9% | 431.9% | 431.9% | 431.9% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -46.8% | -46.8% | -46.8% | -13.0% | -13.0% |
| Gross Margin | — | 90.3% | 90.3% | 90.3% | 94.2% | 94.2% |
| D/E Ratio | — | 996.68 | 996.68 | 996.68 | 996.68 | 996.68 |
| Current Ratio | 4.85 | 4.88 | 4.88 | 4.88 | 4.69 | 4.69 |
Key Ratios
ROA (TTM)
-15.0%
P/S (TTM)
9.02
P/B
7.3
EPS (TTM)
$-0.25
CF/Share
$-0.53
52W High
$9.92
52W Low
$4.68
$4.68
52-Week Range
$9.92
How does FENC compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
FENC valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
9.0
▼
30%
below
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
7.3
▲
195%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
FENC profitability vs Biotechnology peers
ROE
431.9%
▲
742%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-13.0%
▲
95%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
94.2%
▲
20%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-15.0%
▲
68%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
FENC financial health vs Biotechnology peers
D/E ratio
996.7
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
4.7
▲
6%
above
peers
(4.4)
vs Peers
vs Industry
In line
Beta
0.8
▼
22%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
FENC fundamentals radar
FENC
Peer median
Industry
FENC profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio